The Patent Finder

Panoptes Pharma Ges.M.B.H.

Also on record
Records under this name other than the patents Panoptes Pharma Ges.M.B.H. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 5 of 5 · Back to Panoptes Pharma Ges.M.B.H.

PatentTitleStatus Expires Confidence
US 11,730,716Compounds for Treating Ophthalmic Diseases and Disorders
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,364,680Compounds for Treating Ophthalmic Diseases and Disorders
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,472,263Ophthalmic Formulation
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,209,073Polymorphs of a Dihydroorotate Dehydrogenase (DHOD) Inhibitor
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,365,094Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
Term ended
Term ended Oct 25, 2025 · From the USPTO record
Term endedTerm ended Oct 25, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited